LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

Oligomerix

Disease-modifying drugs for Alzheimer\'s disease (AD) and other neurodegenerative disorders.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Oligomerix plus 6131 other startups.

Learn More About Oligomerix

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More